Fibrinogen and risk of cardiovascular disease. The Framingham Study
- PMID: 3626001
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Abstract
During the tenth biennial examination of the Framingham Study, 1315 participants who were free of cardiovascular disease had fibrinogen levels measured. During the ensuing 12 years, cardiovascular disease developed in 165 men and 147 women. For both sexes, the risk of cardiovascular disease was correlated positively to antecedent fibrinogen values higher than the 1.3 to 7.0 g/L (126 to 696 mg/dL) range. The magnitude of the risk diminished with advancing age in women but not in men. Risk for coronary heart disease also was significantly related to fibrinogen level. Here, the magnitude of risk displayed diminishing impact with age, again only in women. Risk of stroke increased progressively with fibrinogen level in men but not in women. The impact of fibrinogen value, considered as a separate variable, on cardiovascular disease was comparable with the major risk factors, such as blood pressure, hematocrit, adiposity, cigarette smoking, and diabetes. Fibrinogen values were also significantly related to these risk factors. Taking all these into account in a multivariate analysis, fibrinogen level was still significantly related to the incidence of cardiovascular disease in men and marginally significant in women. For coronary heart disease, the fibrinogen level was significant for both men and women. Elevated fibrinogen level is a predictor of cardiovascular disease that should be added to the cardiovascular risk factor profile.
Similar articles
-
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study.Am Heart J. 1987 Apr;113(4):1006-10. doi: 10.1016/0002-8703(87)90063-9. Am Heart J. 1987. PMID: 3565227
-
Update on fibrinogen as a cardiovascular risk factor.Ann Epidemiol. 1992 Jul;2(4):457-66. doi: 10.1016/1047-2797(92)90095-8. Ann Epidemiol. 1992. PMID: 1342296
-
Influence of fibrinogen on cardiovascular disease.Drugs. 1997;54 Suppl 3:32-40. doi: 10.2165/00003495-199700543-00006. Drugs. 1997. PMID: 9360850 Review.
-
Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm.J Am Coll Surg. 2000 Dec;191(6):619-25. doi: 10.1016/s1072-7515(00)00759-6. J Am Coll Surg. 2000. PMID: 11129810
-
Fibrinogen and cardiovascular risk.J Cardiovasc Risk. 1995 Jun;2(3):197-205. J Cardiovasc Risk. 1995. PMID: 7584794 Review.
Cited by
-
In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin.Clin Oral Investig. 2013 May;17(4):1273-8. doi: 10.1007/s00784-012-0809-y. Epub 2012 Aug 2. Clin Oral Investig. 2013. PMID: 22855267 Clinical Trial.
-
Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes.J Am Coll Cardiol. 2013 Jul 23;62(4):329-37. doi: 10.1016/j.jacc.2013.03.072. Epub 2013 May 9. J Am Coll Cardiol. 2013. PMID: 23665099 Free PMC article.
-
Oxidation inhibits iron-induced blood coagulation.Curr Drug Targets. 2013 Jan 1;14(1):13-9. doi: 10.2174/1389450111314010003. Curr Drug Targets. 2013. PMID: 23170793 Free PMC article.
-
Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.J Pediatr Endocrinol Metab. 2012;25(1-2):33-40. doi: 10.1515/jpem-2011-0450. J Pediatr Endocrinol Metab. 2012. PMID: 22570948 Free PMC article. Clinical Trial.
-
Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life.BMJ. 1992 Jan 18;304(6820):148-52. doi: 10.1136/bmj.304.6820.148. BMJ. 1992. PMID: 1737158 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources